# The Effect of IV Cangrelor and Oral Ticagrelor Study

> **NCT02733341** · PHASE4 · COMPLETED · sponsor: **The Royal Wolverhampton Hospitals NHS Trust** · enrollment: 100 (actual)

## Conditions studied

- Acute Coronary Syndrome (ACS)
- High On-treatment Platelet Reactivity (HTPR)
- Microvascular Obstruction (MVO)
- ST-segment Elevation Myocardial Infarction (STEMI)
- Thrombolysis in Myocardial Infarction (TIMI)
- Unstable Angina (UA)

## Interventions

- **DRUG:** Cangrelor
- **DRUG:** Ticagrelor

## Key facts

- **NCT ID:** NCT02733341
- **Lead sponsor:** The Royal Wolverhampton Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-21
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-10-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733341, "The Effect of IV Cangrelor and Oral Ticagrelor Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02733341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*